Advertisement

PharmacoEconomics & Outcomes News

, Volume 825, Issue 1, pp 23–23 | Cite as

Managed entry schemes impact reimbursement decisions

Clinical study
  • 7 Downloads

Reference

  1. Van Wilder P, et al. Impact of health technology assessment and managed entry schemes on reimbursement decisions of centrally authorised medicinal products in Belgium. European Journal of Clinical Pharmacology : 15 Mar 2019. Available from: URL: http://doi.org/10.1007/s00228-019-02665-6

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations